Radiotherapy (RT) has been shown to cause immunogenic death of cancer cells, which can trigger DC activation, antigen presentation, and priming of tumor-specific CD8+ T cells15–18, and can be employed for enhancing Flt3L-induced cDC1 function in the tumor. This evidence concerns the gene FLT3LG and cancer.